查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
灌注影像市场：现况分析与预测（2023-2030）
市场调查报告书
商品编码
1364873

灌注影像市场：现况分析与预测（2023-2030）

Perfusion Imaging Market: Current Analysis and Forecast (2023-2030)
出版日期: | 出版商: UnivDatos Market Insights Pvt Ltd | 英文 146 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

从 2023 年到 2030 年，灌注影像市场预计复合年增长率约为 4.3%。 灌注影像是一种医学影像技术，用于评估体内组织和器官的血流量。 它对于诊断和监测中风、心臟病和某些类型的癌症等疾病特别有用。 心血管疾病盛行率的增加推动了灌注影像需求的成长。 例如，根据 CDC 的数据，在美国每 33 秒就有一人死于心血管疾病。 2021年，美国将有约69.5万人死于心臟病，占死亡人数的五分之一。 此外，成像技术的持续进步，包括更高解析度和更有效率的成像技术，是关键驱动因素。 MRI、CT 和核子医学的创新正在提高灌注影像能力。 此外，灌注成像在肿瘤学中的肿瘤检测和评估中发挥重要作用。 全球癌症发生率上升正在推动对灌注成像的需求。 2021 年，癌症仍然是医疗保健领域的关键问题。

依类型划分，市场分为磁振造影、电脑断层扫描、超音波等。 其中，磁振造影领域由于其非侵入性、卓越的软组织对比度以及提供定量灌注数据的能力，预计市场将以更高的复合年增长率成长。 MRI 技术的最新发展，加上新的政府法规，进一步促进了这一领域的成长。 例如，2021 年，Siemens Healthineers 推出了 MAGNETOM Free.Max MRI 系统，该系统采用适合神经影像应用的尖端技术。 该系统为神经学评估提供先进的灌注成像功能。

依用途分为通气灌注造影、心肌灌注造影、脑部功能影像、肿瘤检测等。 其中，心肌灌注影像领域预计将以更高的复合年增长率成长，因为包括冠状动脉疾病（CAD）在内的心血管疾病是全球发病和死亡的主要原因。 MPI 在这些疾病的诊断和评估中发挥着重要作用，推动了该领域的需求。 例如，Siemens Healthineers 推出了 syngo.CT Cardiac Function，这是一款旨在使用 CT 扫描评估心臟功能（包括心肌灌注）的软体应用程式。 儘管这一发展并非特定于使用核医学的 MPI，但它是业界努力扩展心臟影像功能的一个例子。

根据最终用户，市场分为医院、诊断中心和研究机构。 特别是，预计医院在预测期内将增加灌注影像的采用。 医院部门是灌注影像市场的主要驱动力，因为灌注影像在医疗保健服务以及各种医疗状况的诊断和治疗中发挥核心作用。 灌注影像对于治疗计划和监测也至关重要。 医院使用灌注影像来评估医疗状况的范围和严重程度，并帮助规划手术、介入和治疗。 帮助优化患者照护。 此外，快速、准确的诊断对于中风、心肌梗塞和外伤等紧急情况至关重要。 医院正在使用灌注成像进行快速评估，从而能够及时采取干预措施，挽救生命并降低发病率。 例如，世界各地的许多医院将在 2021 年继续扩大其诊断影像部门并使其现代化。 我们投资了先进的灌注影像系统，包括 MRI、CT 和 PET 扫描仪，以提高病患照护和诊断能力。

为了更了解ADNP症候群治疗产业的市场介绍，将市场分为北美（美国、加拿大、北美其他地区）、欧洲（德国、英国、法国、西班牙、义大利、欧洲其他地区） 、亚太地区（根据其他地区（中国、日本、印度、亚太其他地区）和其他地区的全球影响力进行分析。 由于癌症发病率不断上升、医疗保健专业人员和公众对灌注成像的认识不断提高、先进影像处理技术的市场发展以及治疗选择的数量不断增加，北美灌注成像市场将继续增长。 例如，根据美国癌症协会的数据，2020 年，癌症是美国仅次于心臟病的第二大死因。 预计 2022 年美国将有约 609,360 人死于癌症，相当于每天约 1,670 人死亡。

目录

第一章市场介绍

  • 市场定义
  • 主要目标
  • 利害关係人
  • 限制

第二章研究方法或假设

  • 调查过程
  • 调查方法
  • 受访者简介

第三章市场总结

第 4 章执行摘要

第 5 章 COVID-19 对灌注造影市场的影响

第 6 章 2020-2030 年全球灌注影像市场收入

第 7 章按类型划分的市场洞察

  • 磁振造影
  • 电脑断层扫描
  • 超音波
  • 其他

第 8 章按应用划分的市场洞察

  • 通气灌注成像
  • 心肌灌注成像
  • 脑功能影像
  • 肿瘤检测

第 9 章最终使用者的市场洞察

  • 医院和诊所
  • 诊断中心
  • 调查机构

第 10 章按地区划分的市场洞察

  • 北美灌注造影市场
    • 美国
    • 加拿大
    • 其他北美地区
  • 欧洲灌注造影市场
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 其他欧洲地区
  • 亚太灌注造影市场
    • 中国
    • 日本
    • 印度
    • 其他亚太地区
  • 其他地区的灌注影像市场

第 11 章灌注成像市场动态

  • 市场驱动因素
  • 市场挑战
  • 影响分析

第 12 章灌注影像市场机会

第 13 章灌注影像市场趋势与见解

第14章需求面与供给面分析

  • 需求方分析
  • 供给面分析

第 15 章价值链分析

第16章价格分析

第十七章竞争场景

  • 竞争状况
    • 波特五力分析

第十八章公司简介

  • Siemens Healthineers
  • GE Healthcare,
  • Philips Healthcare
  • Bayer AG
  • Medtronic
  • Canon Medical Systems Corporation
  • Shimadzu Corporation
  • Bracco Imaging S.p.A
  • Neusoft Corporation
  • Perimed AB

第十九章免责声明

简介目录
Product Code: UMHE212350

The perfusion imaging market is expected to register a CAGR of approx. 4.3% over the period of 2023-2030. Perfusion imaging is a medical imaging technique used to assess blood flow to tissues and organs in the body. It is particularly valuable in diagnosing and monitoring conditions such as stroke, heart disease, and certain types of cancer. The growing demand for perfusion imaging can be attributed to the increasing incidence of cardiovascular diseases are the key factors which boost the adoption around the globe. For instance, according to the CDC, One person dies every 33 seconds in the United States from cardiovascular disease. About 695,000 people in the United States died from heart disease in 2021-that's 1 in every 5 deaths. Furthermore, ongoing advancements in imaging technology, including higher resolution and more efficient imaging techniques, have been a key driver. Innovations in MRI, CT, and nuclear medicine have enhanced the capabilities of perfusion imaging. Moreover, perfusion imaging plays a crucial role in oncology for the detection and evaluation of tumours. The rising incidence of cancer cases worldwide has driven the demand for perfusion imaging procedures. In 2021, cancer remained a significant healthcare concern.

Based on the type, the market has been categorized into magnetic resonance imaging, computed tomography, ultrasound, and others. Among them, the magnetic resonance imaging segment is expected to grow at a higher CAGR in the market due to its non-invasive nature, excellent soft tissue contrast, and ability to provide quantitative perfusion data. Recent developments in MRI technology, combined with new government regulations, have further contributed to the growth of this segment. For instance, in 2021, Siemens Healthineers introduced the MAGNETOM Free.Max MRI system, which features cutting-edge technology for neuroimaging applications. This system offers advanced perfusion imaging capabilities for neurological assessments.

Based on the application, the market has been categorized into ventilation-perfusion imaging, myocardial perfusion imaging, functional brain imaging, and tumour detection. Among them, the myocardial perfusion imaging segment is expected to grow at a higher CAGR in the market due to Cardiovascular diseases, including coronary artery disease (CAD), are a leading cause of morbidity and mortality worldwide. MPI plays a crucial role in diagnosing and evaluating these conditions, driving demand for this segment. For instance, Siemens Healthineers introduced the syngo.CT Cardiac Function, a software application designed to assess cardiac function, including myocardial perfusion, using CT scans. While this development is not specific to MPI using nuclear medicine, it exemplifies the industry's efforts to expand the capabilities of cardiac imaging.

Based on the end-user, the market has been categorized into hospitals, diagnostic center, and research institutes. Among them, the hospital category is to witness higher adoption of perfusion imaging during the forecast period. The hospitals segment is a key driver of the perfusion imaging market due to its central role in healthcare delivery and the diagnosis and treatment of various medical conditions. In addition, Perfusion imaging is crucial for treatment planning and monitoring. Hospitals use perfusion imaging to assess the extent and severity of conditions, which helps in planning surgeries, interventions, and therapies. It aids in optimizing patient care. Moreover, In emergency situations such as stroke, myocardial infarction, and trauma, quick and accurate diagnosis is critical. Hospitals use perfusion imaging for rapid assessment, enabling timely interventions that can save lives and reduce morbidity. For example, Many hospitals worldwide continued to expand and modernize their imaging departments in 2021. They invested in advanced perfusion imaging systems, such as MRI, CT, and PET scanners, to improve patient care and diagnostic capabilities.

For a better understanding of the market adoption of the ADNP syndrome treatment industry, the market is analyzed based on its worldwide presence in the countries such as North America (U.S., Canada, and Rest of North America), Europe (Germany, U.K., France, Spain, Italy, Rest of Europe), Asia-Pacific (China, Japan, India, Rest of Asia-Pacific), Rest of World. The North America perfusion imaging market is expected to continue to grow in the coming years, driven by the increasing prevalence of cancer and growing awareness of perfusion imaging among healthcare professionals and the general population, development of advanced imaging techniques and the rise in treatment option. For instance, in 2020, according to American Cancer Society, Cancer is the second most common cause of death in the US, exceeded only by heart disease. around 609,360 deaths from cancer are expected in the US in 2022, which is about 1,670 deaths per day.

Some of the major players operating in the market include: Siemens Healthineers, GE Healthcare, Philips Healthcare, Bayer AG, Medtronic, Canon Medical Systems Corporation, Shimadzu Corporation, Bracco Imaging S.p.A, Neusoft Corporation, Perimed AB.

TABLE OF CONTENTS

1 MARKET INTRODUCTION

  • 1.1. Market Definitions
  • 1.2. Main Objective
  • 1.3. Stakeholders
  • 1.4. Limitation

2 RESEARCH METHODOLOGY OR ASSUMPTION

  • 2.1. Research Process of the Perfusion Imaging Market
  • 2.2. Research Methodology of the Perfusion Imaging Market
  • 2.4. Respondent Profile

3 MARKET SYNOPSIS

4 EXECUTIVE SUMMARY

5 IMPACT OF COVID-19 ON THE PERFUSION IMAGING MARKET

6 GLOBAL PERFUSION IMAGING MARKET REVENUE, 2020-2030F

7 MARKET INSIGHTS BY TYPE

  • 7.2. Magnetic Resonance Imaging
  • 7.3. Computed Tomography
  • 7.4. Ultrasound
  • 7.5. Others

8 MARKET INSIGHTS BY APPLICATION

  • 8.1. Ventilation Perfusion Imaging
  • 8.2. Myocardial Perfusion Imaging
  • 8.3. Functional Brain Imaging
  • 8.5. Tumor Detection

9 MARKET INSIGHTS BY END-USERS

  • 9.1. Hospitals and Clinics
  • 9.2. Diagnostic Center
  • 9.3. Research Institutes

10 MARKET INSIGHTS BY REGION

  • 10.1 NORTH AMERICA PERFUSION IMAGING MARKET
    • 10.1.1. U.S.
    • 10.1.2. Canada
    • 10.1.3. Rest of North America
  • 10.2 EUROPE PERFUSION IMAGING MARKET
    • 10.2.1. Germany
    • 10.2.2. U.K.
    • 10.2.3. France
    • 10.2.4. Italy
    • 10.2.5. Spain
    • 10.2.6. Rest of Europe
  • 10.3 ASIA PACIFIC PERFUSION IMAGING MARKET
    • 10.3.1. China
    • 10.3.2. Japan
    • 10.3.3. India
    • 10.3.4. Rest of Asia-Pacific
  • 10.4 REST OF THE WORLD PERFUSION IMAGING MARKET

11 PERFUSION IMAGING MARKET DYNAMICS

  • 11.1. Market Drivers
  • 11.2. Market Challenges
  • 11.3. Impact Analysis

12 PERFUSION IMAGING MARKET OPPORTUNITIES

13 PERFUSION IMAGING MARKET TRENDS & INSIGHTS

14 DEMAND AND SUPPLY SIDE ANALYSIS

  • 14.1. Demand Side Analysis
  • 14.2. Supply Side Analysis

15 VALUE CHAIN ANALYSIS

16 PRICING ANALYSIS

17 COMPETITIVE SCENARIO

  • 17.1. Competitive Landscape
    • 17.1.1 Porter's Five forces analysis

18 COMPANY PROFILED

  • 18.1. Siemens Healthineers
  • 18.2. GE Healthcare,
  • 18.3. Philips Healthcare
  • 18.4. Bayer AG
  • 18.5. Medtronic
  • 18.6. Canon Medical Systems Corporation
  • 18.7. Shimadzu Corporation
  • 18.8. Bracco Imaging S.p.A
  • 18.9. Neusoft Corporation
  • 18.10. Perimed AB

19 DISCLAIMER